Clinical Trials · NCT04344717

Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition

CompletedPhase 4Teduglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment
70
Start date
Dec 2020
Locations
1 site, Belgium
Primary endpoint
Difference in Cmax of apixaban between SBS and patients with a normal gastrointestinal tract
View Teduglutide compound reference